Manufacturer: Lilly, France, for Eli Lilly and Company, Indianapolis, IN Indication: Stimulation of new bone formation in patients with osteoporosis Drug Class: Teriparatide is a recombinant human parathyroid hormone (PTH), which is the primary regulator of calcium and phosphate metabolism in bones. It has an identical sequence to the 34N-terminal amino acids (the biologically active [...]
Continue reading " Pharmaceutical-Approval Update: Teriparatide (rDNA Origin) Injection (Forteo®) "































